BlackRock’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454M | Sell |
40,316,307
-1,343,181
| -3% | -$15.1M | 0.01% | 1113 |
|
|
2025
Q1 | $420M | Sell |
41,659,488
-498,043
| -1% | -$5.03M | 0.01% | 1139 |
|
|
2024
Q4 | $499M | Buy |
42,157,531
+195,472
| +0.5% | +$2.31M | 0.01% | 1089 |
|
|
2024
Q3 | $484M | Buy |
41,962,059
+6,591,789
| +19% | +$76.1M | 0.01% | 1089 |
|
|
2024
Q2 | $374M | Sell |
35,370,270
-817,249
| -2% | -$8.64M | 0.01% | 1195 |
|
|
2024
Q1 | $381M | Buy |
36,187,519
+15,381,918
| +74% | +$162M | 0.01% | 1210 |
|
|
2023
Q4 | $234M | Buy |
20,805,601
+3,082,064
| +17% | +$34.6M | 0.01% | 1540 |
|
|
2023
Q3 | $207M | Buy |
17,723,537
+5,350,664
| +43% | +$62.5M | 0.01% | 1508 |
|
|
2023
Q2 | $125M | Buy |
12,372,873
+6,170,264
| +99% | +$62.2M | ﹤0.01% | 1879 |
|
|
2023
Q1 | $45.8M | Buy |
6,202,609
+86,372
| +1% | +$637K | ﹤0.01% | 2467 |
|
|
2022
Q4 | $48.9M | Buy |
6,116,237
+800,258
| +15% | +$6.39M | ﹤0.01% | 2449 |
|
|
2022
Q3 | $17.1M | Sell |
5,315,979
-112,079
| -2% | -$361K | ﹤0.01% | 3069 |
|
|
2022
Q2 | $22.1M | Buy |
5,428,058
+1,383,639
| +34% | +$5.63M | ﹤0.01% | 2973 |
|
|
2022
Q1 | $20M | Buy |
4,044,419
+117,329
| +3% | +$580K | ﹤0.01% | 3104 |
|
|
2021
Q4 | $39.6M | Buy |
+3,927,090
| New | +$39.6M | ﹤0.01% | 2774 |
|